PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-30.62%
Both yoy net incomes decline, with AVGO at -12.12%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
0.08%
Some D&A expansion while AVGO is negative at -2.40%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
36.67%
Lower deferred tax growth vs. AVGO's 95.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
5.96%
SBC growth while AVGO is negative at -9.52%. John Neff would see competitor possibly controlling share issuance more tightly.
-115.82%
Both reduce yoy usage, with AVGO at -968.42%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-79.87%
AR is negative yoy while AVGO is 80.38%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
159.91%
Inventory shrinking or stable vs. AVGO's 3500.00%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-82.45%
Both negative yoy AP, with AVGO at -183.95%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-110.75%
Both reduce yoy usage, with AVGO at -216.36%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-19.77%
Both negative yoy, with AVGO at -63.16%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-44.44%
Both yoy CFO lines are negative, with AVGO at -18.56%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
3.37%
Some CapEx rise while AVGO is negative at -32.08%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-72.21%
Negative yoy purchasing while AVGO stands at 80.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
136.96%
Liquidation growth of 136.96% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
99.65%
Growth well above AVGO's 17.02%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
26.14%
We have mild expansions while AVGO is negative at -32.81%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-32.10%
We cut debt repayment yoy while AVGO is 8.33%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-100.00%
Negative yoy issuance while AVGO is 30.91%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-1372.22%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.